- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-6606
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Blood-based molecular biomarkers for Alzheimer’s disease ; volume:12 ; number:1 ; day:28 ; month:3 ; year:2019 ; pages:1-7 ; date:12.2019
Molecular brain ; 12, Heft 1 (28.3.2019), 1-7, 12.2019
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13041-019-0448-1
- URN
-
urn:nbn:de:101:1-2019041920234091979963
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zetterberg, Henrik
- Burnham, Samantha C.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Blood-based biomarkers in Alzheimer’s disease – moving towards a new era of diagnostics
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Blood‐based biomarkers for Alzheimer's disease
Classification accuracy of blood-based and neurophysiological markers in the differential diagnosis of Alzheimer’s disease and frontotemporal lobar degeneration
No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF
Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease
Exploring small non-coding RNAs as blood-based biomarkers to predict Alzheimer’s disease
The potential impact of clinical factors on blood-based biomarkers for Alzheimer’s disease
Cerebrospinal Fluid S100B and Alzheimer’s Disease Biomarkers in Hip Fracture Patients with Delirium
Melatonin: A potential nighttime guardian against Alzheimer’s
Blood-based biomarkers in Alzheimer’s disease – moving towards a new era of diagnostics
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Blood‐based biomarkers for Alzheimer's disease
Classification accuracy of blood-based and neurophysiological markers in the differential diagnosis of Alzheimer’s disease and frontotemporal lobar degeneration
No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF
Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease
Exploring small non-coding RNAs as blood-based biomarkers to predict Alzheimer’s disease
The potential impact of clinical factors on blood-based biomarkers for Alzheimer’s disease
Cerebrospinal Fluid S100B and Alzheimer’s Disease Biomarkers in Hip Fracture Patients with Delirium
Melatonin: A potential nighttime guardian against Alzheimer’s
Blood-based biomarkers in Alzheimer’s disease – moving towards a new era of diagnostics
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Blood‐based biomarkers for Alzheimer's disease
Classification accuracy of blood-based and neurophysiological markers in the differential diagnosis of Alzheimer’s disease and frontotemporal lobar degeneration
No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF
Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease
Exploring small non-coding RNAs as blood-based biomarkers to predict Alzheimer’s disease
The potential impact of clinical factors on blood-based biomarkers for Alzheimer’s disease
Cerebrospinal Fluid S100B and Alzheimer’s Disease Biomarkers in Hip Fracture Patients with Delirium